Project
Inflammatory response time course, HUVEC (Wada, 2009)
Navigation
Downloads
Results for RCOR1_MTA3
Z-value: 1.63
Motif logo
Transcription factors associated with RCOR1_MTA3
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RCOR1
|
ENSG00000089902.10 | RCOR1 |
|
MTA3
|
ENSG00000057935.14 | MTA3 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MTA3 | hg38_v1_chr2_+_42568605_42568684 | 0.71 | 6.8e-05 | Click! |
| RCOR1 | hg38_v1_chr14_+_102592611_102592668 | 0.49 | 1.4e-02 | Click! |
Activity profile of RCOR1_MTA3 motif
Sorted Z-values of RCOR1_MTA3 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of RCOR1_MTA3
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_+_111898592 | 9.57 |
ENST00000295408.9
ENST00000421804.6 ENST00000616902.4 ENST00000409780.5 |
MERTK
|
MER proto-oncogene, tyrosine kinase |
| chr4_+_41360759 | 8.46 |
ENST00000508501.5
ENST00000512946.5 ENST00000313860.11 ENST00000512632.5 ENST00000512820.5 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr3_-_64445396 | 7.85 |
ENST00000295902.11
|
PRICKLE2
|
prickle planar cell polarity protein 2 |
| chr7_+_1044542 | 7.81 |
ENST00000444847.2
|
GPR146
|
G protein-coupled receptor 146 |
| chr3_+_37861849 | 7.63 |
ENST00000273179.10
|
CTDSPL
|
CTD small phosphatase like |
| chr1_+_99646025 | 7.61 |
ENST00000263174.9
ENST00000605497.5 ENST00000615664.1 |
PALMD
|
palmdelphin |
| chr2_+_238138661 | 7.54 |
ENST00000409223.2
|
KLHL30
|
kelch like family member 30 |
| chr12_-_42483604 | 7.27 |
ENST00000640132.1
|
PRICKLE1
|
prickle planar cell polarity protein 1 |
| chr2_-_105398978 | 7.16 |
ENST00000408995.5
ENST00000530340.6 ENST00000393353.7 ENST00000322142.13 ENST00000344213.9 ENST00000358129.8 |
FHL2
|
four and a half LIM domains 2 |
| chr21_-_44592505 | 7.15 |
ENST00000400368.1
|
KRTAP10-6
|
keratin associated protein 10-6 |
| chr3_+_37861926 | 6.74 |
ENST00000443503.6
|
CTDSPL
|
CTD small phosphatase like |
| chr8_-_9150648 | 6.60 |
ENST00000310455.4
|
PPP1R3B
|
protein phosphatase 1 regulatory subunit 3B |
| chr18_+_11981488 | 6.28 |
ENST00000269159.8
|
IMPA2
|
inositol monophosphatase 2 |
| chr12_+_53046969 | 6.22 |
ENST00000379902.7
|
TNS2
|
tensin 2 |
| chr6_+_142301926 | 6.14 |
ENST00000296932.13
ENST00000367609.8 |
ADGRG6
|
adhesion G protein-coupled receptor G6 |
| chr7_-_38631356 | 6.12 |
ENST00000356264.7
ENST00000325590.9 |
AMPH
|
amphiphysin |
| chrX_-_63351308 | 6.04 |
ENST00000374884.3
|
SPIN4
|
spindlin family member 4 |
| chr12_-_42483958 | 6.01 |
ENST00000548696.6
ENST00000552240.6 |
PRICKLE1
|
prickle planar cell polarity protein 1 |
| chr7_+_80134794 | 6.01 |
ENST00000649796.2
|
GNAI1
|
G protein subunit alpha i1 |
| chr21_+_44600597 | 5.99 |
ENST00000609664.2
|
KRTAP10-7
|
keratin associated protein 10-7 |
| chr8_+_119208322 | 5.98 |
ENST00000614891.5
|
MAL2
|
mal, T cell differentiation protein 2 |
| chr18_+_23135452 | 5.85 |
ENST00000580153.5
ENST00000256925.12 |
CABLES1
|
Cdk5 and Abl enzyme substrate 1 |
| chr9_-_75088140 | 5.83 |
ENST00000361092.9
ENST00000376811.5 |
NMRK1
|
nicotinamide riboside kinase 1 |
| chr20_-_40689228 | 5.77 |
ENST00000373313.3
|
MAFB
|
MAF bZIP transcription factor B |
| chr10_-_124092445 | 5.69 |
ENST00000346248.7
|
CHST15
|
carbohydrate sulfotransferase 15 |
| chr14_+_24398986 | 5.68 |
ENST00000382554.4
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr2_-_189580773 | 5.65 |
ENST00000261024.7
|
SLC40A1
|
solute carrier family 40 member 1 |
| chr11_+_59787067 | 5.57 |
ENST00000528805.1
|
STX3
|
syntaxin 3 |
| chr5_+_69492767 | 5.54 |
ENST00000681041.1
ENST00000680098.1 ENST00000680784.1 ENST00000396442.7 ENST00000681895.1 |
OCLN
|
occludin |
| chr20_+_43916142 | 5.47 |
ENST00000423191.6
ENST00000372999.5 |
TOX2
|
TOX high mobility group box family member 2 |
| chr2_+_48530132 | 5.45 |
ENST00000404752.6
ENST00000406226.1 |
STON1
|
stonin 1 |
| chr21_+_44697427 | 5.41 |
ENST00000618832.1
|
KRTAP10-12
|
keratin associated protein 10-12 |
| chr6_+_142301854 | 5.40 |
ENST00000230173.10
ENST00000367608.6 |
ADGRG6
|
adhesion G protein-coupled receptor G6 |
| chr6_-_13486137 | 5.35 |
ENST00000612338.4
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
| chr4_+_6277309 | 5.34 |
ENST00000684087.1
ENST00000674051.1 ENST00000682059.1 ENST00000684054.1 ENST00000684700.1 ENST00000683395.1 |
WFS1
|
wolframin ER transmembrane glycoprotein |
| chr10_+_110871903 | 5.30 |
ENST00000280154.12
|
PDCD4
|
programmed cell death 4 |
| chr4_+_125314918 | 5.22 |
ENST00000674496.2
ENST00000394329.9 |
FAT4
|
FAT atypical cadherin 4 |
| chr7_+_90211830 | 5.12 |
ENST00000394622.6
ENST00000394632.5 ENST00000426158.1 ENST00000402625.6 |
STEAP2
|
STEAP2 metalloreductase |
| chr2_-_55269038 | 5.08 |
ENST00000417363.5
ENST00000412530.1 ENST00000366137.6 ENST00000420637.5 |
MTIF2
|
mitochondrial translational initiation factor 2 |
| chr12_+_27244222 | 5.04 |
ENST00000545470.5
ENST00000389032.8 ENST00000540996.5 |
STK38L
|
serine/threonine kinase 38 like |
| chr4_+_184649661 | 4.99 |
ENST00000515774.5
ENST00000503752.5 |
PRIMPOL
|
primase and DNA directed polymerase |
| chr12_+_53050179 | 4.96 |
ENST00000546602.5
ENST00000552570.5 ENST00000549700.5 |
TNS2
|
tensin 2 |
| chrX_+_102712438 | 4.94 |
ENST00000486814.2
ENST00000535209.6 ENST00000543253.6 ENST00000332262.10 ENST00000483720.6 |
GPRASP2
|
G protein-coupled receptor associated sorting protein 2 |
| chr10_+_110871789 | 4.91 |
ENST00000393104.6
|
PDCD4
|
programmed cell death 4 |
| chr20_-_23049659 | 4.88 |
ENST00000377103.3
|
THBD
|
thrombomodulin |
| chr5_+_52989314 | 4.86 |
ENST00000296585.10
|
ITGA2
|
integrin subunit alpha 2 |
| chr13_-_48533069 | 4.86 |
ENST00000344532.8
|
RCBTB2
|
RCC1 and BTB domain containing protein 2 |
| chr1_+_34792990 | 4.86 |
ENST00000450137.1
ENST00000342280.5 |
GJA4
|
gap junction protein alpha 4 |
| chr9_+_136712531 | 4.83 |
ENST00000371692.9
|
DIPK1B
|
divergent protein kinase domain 1B |
| chr14_-_104953899 | 4.81 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
| chr1_+_25616780 | 4.74 |
ENST00000374332.9
|
MAN1C1
|
mannosidase alpha class 1C member 1 |
| chr11_+_59755365 | 4.72 |
ENST00000337979.9
|
STX3
|
syntaxin 3 |
| chr12_-_94650506 | 4.72 |
ENST00000261226.9
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr6_+_17393576 | 4.71 |
ENST00000229922.7
ENST00000611958.4 |
CAP2
|
cyclase associated actin cytoskeleton regulatory protein 2 |
| chrX_-_126552801 | 4.68 |
ENST00000371126.3
|
DCAF12L1
|
DDB1 and CUL4 associated factor 12 like 1 |
| chr21_+_17513003 | 4.66 |
ENST00000284878.12
ENST00000400166.5 |
CXADR
|
CXADR Ig-like cell adhesion molecule |
| chr1_+_156893678 | 4.61 |
ENST00000292357.8
ENST00000338302.7 ENST00000455314.5 |
PEAR1
|
platelet endothelial aggregation receptor 1 |
| chr6_-_129710145 | 4.57 |
ENST00000368149.3
|
ARHGAP18
|
Rho GTPase activating protein 18 |
| chr4_+_6269869 | 4.51 |
ENST00000506362.2
|
WFS1
|
wolframin ER transmembrane glycoprotein |
| chr12_-_47079926 | 4.51 |
ENST00000429635.1
ENST00000550413.2 |
AMIGO2
|
adhesion molecule with Ig like domain 2 |
| chr9_+_76459152 | 4.51 |
ENST00000444201.6
ENST00000376730.5 |
GCNT1
|
glucosaminyl (N-acetyl) transferase 1 |
| chr9_-_75088198 | 4.50 |
ENST00000376808.8
|
NMRK1
|
nicotinamide riboside kinase 1 |
| chr7_+_12686849 | 4.50 |
ENST00000396662.5
ENST00000356797.7 ENST00000396664.2 |
ARL4A
|
ADP ribosylation factor like GTPase 4A |
| chr7_+_80135079 | 4.48 |
ENST00000649634.1
|
GNAI1
|
G protein subunit alpha i1 |
| chr13_-_43879696 | 4.47 |
ENST00000444614.8
|
CCDC122
|
coiled-coil domain containing 122 |
| chr9_+_137077467 | 4.46 |
ENST00000409858.8
|
UAP1L1
|
UDP-N-acetylglucosamine pyrophosphorylase 1 like 1 |
| chr10_+_35127162 | 4.41 |
ENST00000354759.7
|
CREM
|
cAMP responsive element modulator |
| chr1_-_91886144 | 4.41 |
ENST00000212355.9
|
TGFBR3
|
transforming growth factor beta receptor 3 |
| chr7_+_1055285 | 4.40 |
ENST00000397095.2
|
GPR146
|
G protein-coupled receptor 146 |
| chr4_+_184649716 | 4.39 |
ENST00000512834.5
ENST00000314970.11 |
PRIMPOL
|
primase and DNA directed polymerase |
| chr3_+_39809602 | 4.37 |
ENST00000302541.11
ENST00000396217.7 |
MYRIP
|
myosin VIIA and Rab interacting protein |
| chr3_-_64268161 | 4.35 |
ENST00000564377.6
|
PRICKLE2
|
prickle planar cell polarity protein 2 |
| chr13_-_48533165 | 4.35 |
ENST00000430805.6
ENST00000544492.5 ENST00000544904.3 |
RCBTB2
|
RCC1 and BTB domain containing protein 2 |
| chr8_-_73746830 | 4.33 |
ENST00000524300.6
ENST00000523558.5 ENST00000521210.5 ENST00000355780.9 ENST00000524104.5 ENST00000521736.5 ENST00000521447.5 ENST00000517542.5 ENST00000521451.5 ENST00000521419.5 ENST00000518502.5 |
STAU2
|
staufen double-stranded RNA binding protein 2 |
| chr7_+_90211686 | 4.32 |
ENST00000287908.7
ENST00000394621.7 ENST00000394626.5 |
STEAP2
|
STEAP2 metalloreductase |
| chr11_+_59755427 | 4.28 |
ENST00000529177.5
|
STX3
|
syntaxin 3 |
| chr4_+_155667198 | 4.27 |
ENST00000296518.11
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
| chr11_+_59755398 | 4.26 |
ENST00000633708.1
|
STX3
|
syntaxin 3 |
| chr10_+_23095556 | 4.23 |
ENST00000376510.8
|
MSRB2
|
methionine sulfoxide reductase B2 |
| chr3_+_58237773 | 4.23 |
ENST00000478253.6
|
ABHD6
|
abhydrolase domain containing 6, acylglycerol lipase |
| chr3_-_149086488 | 4.21 |
ENST00000392912.6
ENST00000465259.5 ENST00000310053.10 ENST00000494055.5 |
HLTF
|
helicase like transcription factor |
| chr3_-_15859771 | 4.20 |
ENST00000399451.6
|
ANKRD28
|
ankyrin repeat domain 28 |
| chr6_-_83709019 | 4.17 |
ENST00000519779.5
ENST00000369694.6 ENST00000195649.10 |
SNAP91
|
synaptosome associated protein 91 |
| chr4_+_155667096 | 4.14 |
ENST00000393832.7
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
| chr12_-_47079859 | 4.13 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig like domain 2 |
| chr6_+_117482634 | 4.08 |
ENST00000296955.12
ENST00000338728.10 |
DCBLD1
|
discoidin, CUB and LCCL domain containing 1 |
| chr7_+_150991005 | 4.08 |
ENST00000297494.8
|
NOS3
|
nitric oxide synthase 3 |
| chr16_-_30021288 | 4.07 |
ENST00000574405.5
|
DOC2A
|
double C2 domain alpha |
| chr4_-_148444674 | 4.06 |
ENST00000344721.8
|
NR3C2
|
nuclear receptor subfamily 3 group C member 2 |
| chr1_+_77888490 | 4.04 |
ENST00000401035.7
ENST00000330010.12 |
NEXN
|
nexilin F-actin binding protein |
| chr12_+_53050014 | 4.01 |
ENST00000314250.11
|
TNS2
|
tensin 2 |
| chr1_+_25543598 | 3.99 |
ENST00000374338.5
|
LDLRAP1
|
low density lipoprotein receptor adaptor protein 1 |
| chr2_-_156342348 | 3.98 |
ENST00000409572.5
|
NR4A2
|
nuclear receptor subfamily 4 group A member 2 |
| chr4_+_155666827 | 3.87 |
ENST00000511507.5
ENST00000506455.6 |
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
| chr2_+_11155498 | 3.87 |
ENST00000402361.5
ENST00000428481.1 |
SLC66A3
|
solute carrier family 66 member 3 |
| chr8_-_92095627 | 3.87 |
ENST00000517919.5
ENST00000617740.4 ENST00000613302.4 ENST00000436581.6 ENST00000614812.4 ENST00000519847.5 |
RUNX1T1
|
RUNX1 partner transcriptional co-repressor 1 |
| chr8_-_124372686 | 3.86 |
ENST00000297632.8
|
TMEM65
|
transmembrane protein 65 |
| chr20_+_31605280 | 3.86 |
ENST00000376105.4
ENST00000376112.4 |
ID1
|
inhibitor of DNA binding 1, HLH protein |
| chr5_+_69415065 | 3.86 |
ENST00000647531.1
ENST00000645446.1 ENST00000325631.10 ENST00000454295.6 |
MARVELD2
|
MARVEL domain containing 2 |
| chr1_-_204152010 | 3.85 |
ENST00000367202.9
|
ETNK2
|
ethanolamine kinase 2 |
| chr4_+_42397473 | 3.85 |
ENST00000319234.5
|
SHISA3
|
shisa family member 3 |
| chr19_-_11197516 | 3.80 |
ENST00000592903.5
ENST00000586659.6 ENST00000589359.5 ENST00000588724.5 |
KANK2
|
KN motif and ankyrin repeat domains 2 |
| chr17_+_70169516 | 3.80 |
ENST00000243457.4
|
KCNJ2
|
potassium inwardly rectifying channel subfamily J member 2 |
| chr11_+_7513966 | 3.80 |
ENST00000299492.9
|
PPFIBP2
|
PPFIA binding protein 2 |
| chr8_+_94895763 | 3.80 |
ENST00000523378.5
|
NDUFAF6
|
NADH:ubiquinone oxidoreductase complex assembly factor 6 |
| chr18_+_79400274 | 3.79 |
ENST00000545796.5
ENST00000318065.9 ENST00000592223.5 ENST00000329101.8 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T cells 1 |
| chr19_+_2476118 | 3.76 |
ENST00000215631.9
ENST00000587345.1 |
GADD45B
|
growth arrest and DNA damage inducible beta |
| chr7_-_149773207 | 3.74 |
ENST00000484747.5
|
ZNF467
|
zinc finger protein 467 |
| chr9_-_35749165 | 3.73 |
ENST00000378094.4
ENST00000378103.7 |
GBA2
|
glucosylceramidase beta 2 |
| chr3_+_12796662 | 3.69 |
ENST00000456430.6
ENST00000626378.1 |
CAND2
|
cullin associated and neddylation dissociated 2 (putative) |
| chr3_-_52445085 | 3.68 |
ENST00000475739.1
ENST00000231721.7 |
SEMA3G
|
semaphorin 3G |
| chr16_-_88706353 | 3.67 |
ENST00000567844.1
ENST00000312838.9 |
RNF166
|
ring finger protein 166 |
| chr1_+_78045956 | 3.66 |
ENST00000370759.4
|
GIPC2
|
GIPC PDZ domain containing family member 2 |
| chr12_+_32399517 | 3.65 |
ENST00000534526.7
|
FGD4
|
FYVE, RhoGEF and PH domain containing 4 |
| chr9_-_39288303 | 3.65 |
ENST00000377656.6
ENST00000377659.1 |
CNTNAP3
|
contactin associated protein family member 3 |
| chr4_+_87006988 | 3.65 |
ENST00000307808.10
|
AFF1
|
AF4/FMR2 family member 1 |
| chr3_+_44584953 | 3.62 |
ENST00000441021.5
ENST00000322734.2 |
ZNF660
|
zinc finger protein 660 |
| chr15_-_34367159 | 3.61 |
ENST00000314891.11
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
| chr8_-_126558461 | 3.61 |
ENST00000304916.4
|
LRATD2
|
LRAT domain containing 2 |
| chr7_-_120858066 | 3.60 |
ENST00000222747.8
|
TSPAN12
|
tetraspanin 12 |
| chr16_-_88703611 | 3.59 |
ENST00000541206.6
|
RNF166
|
ring finger protein 166 |
| chr9_+_137277698 | 3.58 |
ENST00000357503.3
|
TOR4A
|
torsin family 4 member A |
| chr7_+_87345656 | 3.57 |
ENST00000331536.8
ENST00000419147.6 ENST00000412227.6 |
CROT
|
carnitine O-octanoyltransferase |
| chr4_+_155666963 | 3.57 |
ENST00000455639.6
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
| chr9_-_39288138 | 3.56 |
ENST00000297668.10
|
CNTNAP3
|
contactin associated protein family member 3 |
| chr6_+_25279359 | 3.53 |
ENST00000329474.7
|
CARMIL1
|
capping protein regulator and myosin 1 linker 1 |
| chr22_+_22704265 | 3.52 |
ENST00000390307.2
|
IGLV3-22
|
immunoglobulin lambda variable 3-22 |
| chrX_-_63785510 | 3.51 |
ENST00000437457.6
ENST00000374878.5 ENST00000623517.3 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor 9 |
| chr19_-_11339573 | 3.51 |
ENST00000222120.8
|
RAB3D
|
RAB3D, member RAS oncogene family |
| chr1_-_58546693 | 3.50 |
ENST00000456980.5
ENST00000482274.2 ENST00000453710.1 ENST00000371226.8 ENST00000419242.5 ENST00000426139.5 |
OMA1
|
OMA1 zinc metallopeptidase |
| chr6_+_35452314 | 3.49 |
ENST00000229769.3
|
FANCE
|
FA complementation group E |
| chr1_+_92029971 | 3.49 |
ENST00000370383.5
|
EPHX4
|
epoxide hydrolase 4 |
| chr17_-_83051748 | 3.47 |
ENST00000320865.3
|
B3GNTL1
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase like 1 |
| chr9_+_2157647 | 3.47 |
ENST00000452193.5
ENST00000324954.10 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr10_-_24952573 | 3.46 |
ENST00000376378.5
ENST00000376376.3 ENST00000320152.11 |
PRTFDC1
|
phosphoribosyl transferase domain containing 1 |
| chr14_-_21526312 | 3.46 |
ENST00000537235.2
|
SALL2
|
spalt like transcription factor 2 |
| chr6_+_85450033 | 3.45 |
ENST00000257770.8
ENST00000369646.7 |
NT5E
|
5'-nucleotidase ecto |
| chr10_+_8054808 | 3.45 |
ENST00000346208.4
|
GATA3
|
GATA binding protein 3 |
| chr8_-_92103217 | 3.44 |
ENST00000615601.4
ENST00000523629.5 |
RUNX1T1
|
RUNX1 partner transcriptional co-repressor 1 |
| chr18_+_62325269 | 3.44 |
ENST00000639222.1
ENST00000269485.11 ENST00000616710.4 ENST00000617039.4 |
TNFRSF11A
|
TNF receptor superfamily member 11a |
| chr7_-_11832190 | 3.43 |
ENST00000423059.9
ENST00000617773.1 |
THSD7A
|
thrombospondin type 1 domain containing 7A |
| chr15_-_70763539 | 3.43 |
ENST00000322954.11
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
| chr16_+_8674605 | 3.42 |
ENST00000268251.13
|
ABAT
|
4-aminobutyrate aminotransferase |
| chr20_+_64255728 | 3.41 |
ENST00000369758.8
ENST00000308824.11 ENST00000609372.1 ENST00000610196.1 ENST00000609764.1 |
PCMTD2
|
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 |
| chr17_-_5583957 | 3.39 |
ENST00000354411.7
ENST00000577119.5 |
NLRP1
|
NLR family pyrin domain containing 1 |
| chr8_-_126557691 | 3.39 |
ENST00000652209.1
|
LRATD2
|
LRAT domain containing 2 |
| chr18_+_11981015 | 3.39 |
ENST00000589238.5
|
IMPA2
|
inositol monophosphatase 2 |
| chr14_+_99793329 | 3.38 |
ENST00000334192.8
|
EML1
|
EMAP like 1 |
| chr14_-_91060113 | 3.37 |
ENST00000536315.6
|
RPS6KA5
|
ribosomal protein S6 kinase A5 |
| chr4_+_6269831 | 3.37 |
ENST00000503569.5
ENST00000673991.1 ENST00000682275.1 ENST00000226760.5 |
WFS1
|
wolframin ER transmembrane glycoprotein |
| chr6_+_17393505 | 3.37 |
ENST00000616440.4
|
CAP2
|
cyclase associated actin cytoskeleton regulatory protein 2 |
| chr12_+_20368495 | 3.37 |
ENST00000359062.4
|
PDE3A
|
phosphodiesterase 3A |
| chr12_+_3077355 | 3.37 |
ENST00000537971.5
ENST00000011898.10 ENST00000649909.1 |
TSPAN9
|
tetraspanin 9 |
| chr22_+_25069819 | 3.37 |
ENST00000401395.1
|
KIAA1671
|
KIAA1671 |
| chr7_-_149773548 | 3.36 |
ENST00000302017.4
|
ZNF467
|
zinc finger protein 467 |
| chr14_-_53956811 | 3.34 |
ENST00000559087.5
ENST00000245451.9 |
BMP4
|
bone morphogenetic protein 4 |
| chr15_-_70763430 | 3.34 |
ENST00000539319.5
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
| chr4_+_122826679 | 3.34 |
ENST00000264498.8
|
FGF2
|
fibroblast growth factor 2 |
| chr17_-_78128630 | 3.33 |
ENST00000306591.11
|
TMC6
|
transmembrane channel like 6 |
| chr22_-_37519528 | 3.33 |
ENST00000403299.5
|
CARD10
|
caspase recruitment domain family member 10 |
| chr10_+_8054668 | 3.33 |
ENST00000379328.9
|
GATA3
|
GATA binding protein 3 |
| chr4_-_109703408 | 3.32 |
ENST00000352981.7
ENST00000265164.7 ENST00000505486.1 |
CASP6
|
caspase 6 |
| chr14_-_53953415 | 3.32 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr17_-_35795592 | 3.32 |
ENST00000615136.4
ENST00000605424.6 ENST00000612672.1 |
MMP28
|
matrix metallopeptidase 28 |
| chrX_+_9786420 | 3.32 |
ENST00000380913.8
|
SHROOM2
|
shroom family member 2 |
| chr14_-_29927801 | 3.31 |
ENST00000331968.11
|
PRKD1
|
protein kinase D1 |
| chr4_+_155667654 | 3.31 |
ENST00000513574.1
|
GUCY1A1
|
guanylate cyclase 1 soluble subunit alpha 1 |
| chr22_+_22818994 | 3.30 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 |
| chr1_-_204151884 | 3.30 |
ENST00000367201.7
|
ETNK2
|
ethanolamine kinase 2 |
| chr18_+_11981548 | 3.29 |
ENST00000588927.5
|
IMPA2
|
inositol monophosphatase 2 |
| chr6_-_83709141 | 3.29 |
ENST00000521743.5
|
SNAP91
|
synaptosome associated protein 91 |
| chr11_+_71527267 | 3.28 |
ENST00000398536.6
|
KRTAP5-7
|
keratin associated protein 5-7 |
| chr1_+_220879434 | 3.26 |
ENST00000366903.8
|
HLX
|
H2.0 like homeobox |
| chr2_-_70553440 | 3.25 |
ENST00000450929.5
|
TGFA
|
transforming growth factor alpha |
| chr4_+_185396834 | 3.25 |
ENST00000335174.6
|
ANKRD37
|
ankyrin repeat domain 37 |
| chr1_-_58577244 | 3.23 |
ENST00000371225.4
|
TACSTD2
|
tumor associated calcium signal transducer 2 |
| chr14_-_29927473 | 3.22 |
ENST00000616995.4
|
PRKD1
|
protein kinase D1 |
| chr6_-_73452124 | 3.20 |
ENST00000680833.1
|
CGAS
|
cyclic GMP-AMP synthase |
| chr12_+_122835426 | 3.19 |
ENST00000253083.9
|
HIP1R
|
huntingtin interacting protein 1 related |
| chr4_-_89836963 | 3.19 |
ENST00000420646.6
ENST00000673718.1 |
SNCA
|
synuclein alpha |
| chr2_+_6917404 | 3.18 |
ENST00000320892.11
|
RNF144A
|
ring finger protein 144A |
| chr8_-_80171106 | 3.18 |
ENST00000519303.6
|
TPD52
|
tumor protein D52 |
| chr20_-_25058168 | 3.18 |
ENST00000432802.6
|
ACSS1
|
acyl-CoA synthetase short chain family member 1 |
| chrX_+_72069659 | 3.17 |
ENST00000631375.1
|
NHSL2
|
NHS like 2 |
| chr14_+_76761453 | 3.16 |
ENST00000167106.9
|
VASH1
|
vasohibin 1 |
| chr6_+_84033717 | 3.15 |
ENST00000257776.5
|
MRAP2
|
melanocortin 2 receptor accessory protein 2 |
| chr15_-_34367045 | 3.12 |
ENST00000617710.4
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
| chr1_-_32702736 | 3.12 |
ENST00000373484.4
ENST00000409190.8 |
SYNC
|
syncoilin, intermediate filament protein |
| chr7_+_80133830 | 3.10 |
ENST00000648098.1
ENST00000648476.1 ENST00000648412.1 ENST00000648953.1 ENST00000648306.1 ENST00000648832.1 ENST00000648877.1 ENST00000442586.2 ENST00000649487.1 ENST00000649267.1 |
GNAI1
|
G protein subunit alpha i1 |
| chr2_-_264024 | 3.09 |
ENST00000403712.6
ENST00000356150.10 ENST00000626873.2 ENST00000405430.5 |
SH3YL1
|
SH3 and SYLF domain containing 1 |
| chr16_-_88706262 | 3.09 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
| chr10_+_35127023 | 3.08 |
ENST00000429130.7
ENST00000469949.6 ENST00000460270.5 |
CREM
|
cAMP responsive element modulator |
| chr20_-_25058115 | 3.08 |
ENST00000323482.9
|
ACSS1
|
acyl-CoA synthetase short chain family member 1 |
| chr11_+_45922640 | 3.08 |
ENST00000401752.6
ENST00000325468.9 |
LARGE2
|
LARGE xylosyl- and glucuronyltransferase 2 |
| chr16_+_55509006 | 3.07 |
ENST00000262134.10
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
| chr1_+_63367619 | 3.07 |
ENST00000263440.6
|
ALG6
|
ALG6 alpha-1,3-glucosyltransferase |
| chr2_+_108534353 | 3.06 |
ENST00000544547.5
|
LIMS1
|
LIM zinc finger domain containing 1 |
| chr2_+_233059838 | 3.06 |
ENST00000359570.9
|
INPP5D
|
inositol polyphosphate-5-phosphatase D |
| chr12_+_93571664 | 3.06 |
ENST00000622746.4
ENST00000548537.1 |
SOCS2
|
suppressor of cytokine signaling 2 |
| chrX_+_102712471 | 3.05 |
ENST00000652409.1
|
ARMCX5-GPRASP2
|
ARMCX5-GPRASP2 readthrough |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 13.2 | GO:1903892 | negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 3.8 | 18.8 | GO:2000691 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 3.8 | 11.3 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 3.0 | 8.9 | GO:0055020 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 2.7 | 8.1 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 2.6 | 5.3 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) |
| 2.4 | 9.6 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 2.3 | 6.9 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 2.2 | 13.0 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 2.1 | 6.4 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 2.1 | 6.2 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 2.1 | 6.2 | GO:0031550 | positive regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031550) |
| 2.0 | 20.4 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 2.0 | 6.1 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 1.9 | 7.7 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 1.8 | 7.2 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.8 | 1.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
| 1.8 | 5.4 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 1.8 | 7.0 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.7 | 5.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 1.7 | 12.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 1.7 | 8.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.7 | 8.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 1.7 | 9.9 | GO:0006574 | valine catabolic process(GO:0006574) |
| 1.6 | 4.9 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 1.6 | 6.5 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 1.6 | 4.8 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 1.6 | 4.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 1.6 | 6.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.6 | 9.3 | GO:1903285 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 1.6 | 6.2 | GO:0021649 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 1.5 | 4.5 | GO:0070662 | mast cell proliferation(GO:0070662) |
| 1.5 | 5.9 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.5 | 5.9 | GO:1904980 | positive regulation of endosome organization(GO:1904980) |
| 1.5 | 10.2 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.4 | 2.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.4 | 11.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 1.4 | 1.4 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 1.4 | 5.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 1.4 | 4.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.4 | 4.1 | GO:0060003 | copper ion export(GO:0060003) |
| 1.4 | 4.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.4 | 9.5 | GO:0015677 | copper ion import(GO:0015677) |
| 1.3 | 4.0 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.3 | 5.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 1.3 | 4.0 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 1.3 | 7.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 1.3 | 5.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.3 | 5.0 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
| 1.3 | 3.8 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
| 1.3 | 3.8 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.2 | 5.0 | GO:1904448 | gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.2 | 3.7 | GO:0042938 | dipeptide transport(GO:0042938) |
| 1.2 | 3.7 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 1.2 | 4.9 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 1.2 | 7.2 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 1.2 | 3.5 | GO:0033869 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 1.2 | 5.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 1.2 | 9.3 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 1.1 | 3.4 | GO:0036049 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 1.1 | 1.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.1 | 1.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.1 | 3.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 1.1 | 3.4 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 1.1 | 3.3 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 1.1 | 4.4 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.1 | 3.3 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 1.1 | 3.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.1 | 3.2 | GO:0046707 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 1.1 | 15.9 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 1.1 | 7.4 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.1 | 3.2 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 1.1 | 9.5 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.1 | 21.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.0 | 3.1 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 1.0 | 5.1 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) |
| 1.0 | 3.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 1.0 | 6.1 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
| 1.0 | 5.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.0 | 4.0 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 1.0 | 3.0 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 1.0 | 3.0 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 1.0 | 5.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 1.0 | 7.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 1.0 | 2.9 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.0 | 10.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 1.0 | 10.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.0 | 2.9 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 1.0 | 2.9 | GO:0051695 | actin filament uncapping(GO:0051695) |
| 1.0 | 5.7 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 1.0 | 2.9 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 1.0 | 1.0 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 1.0 | 3.8 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.9 | 2.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.9 | 2.8 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.9 | 4.7 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.9 | 3.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.9 | 0.9 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.9 | 3.7 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.9 | 3.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.9 | 4.6 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.9 | 2.8 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.9 | 3.7 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.9 | 5.5 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.9 | 2.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.9 | 3.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.9 | 2.7 | GO:0072720 | response to dithiothreitol(GO:0072720) |
| 0.9 | 4.4 | GO:0019075 | virus maturation(GO:0019075) |
| 0.9 | 6.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
| 0.9 | 4.4 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.9 | 2.6 | GO:1902299 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.9 | 3.5 | GO:0034553 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.9 | 4.4 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.9 | 0.9 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.9 | 8.6 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.9 | 2.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.8 | 5.1 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.8 | 4.2 | GO:0046056 | dADP metabolic process(GO:0046056) |
| 0.8 | 0.8 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.8 | 3.4 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.8 | 2.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.8 | 0.8 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.8 | 10.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.8 | 6.7 | GO:0060025 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) |
| 0.8 | 1.7 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.8 | 2.5 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
| 0.8 | 2.5 | GO:1903989 | positive regulation of iron ion transport(GO:0034758) positive regulation of iron ion transmembrane transport(GO:0034761) regulation of iron ion import(GO:1900390) regulation of ferrous iron import into cell(GO:1903989) positive regulation of ferrous iron import into cell(GO:1903991) regulation of ferrous iron binding(GO:1904432) positive regulation of ferrous iron binding(GO:1904434) regulation of transferrin receptor binding(GO:1904435) positive regulation of transferrin receptor binding(GO:1904437) regulation of ferrous iron import across plasma membrane(GO:1904438) positive regulation of ferrous iron import across plasma membrane(GO:1904440) |
| 0.8 | 3.3 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
| 0.8 | 2.5 | GO:0014813 | skeletal muscle satellite cell commitment(GO:0014813) |
| 0.8 | 2.5 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.8 | 3.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.8 | 4.9 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.8 | 2.5 | GO:0036233 | glycine import(GO:0036233) |
| 0.8 | 4.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.8 | 1.6 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.8 | 4.9 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
| 0.8 | 11.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.8 | 3.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.8 | 2.4 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) regulation of neurofibrillary tangle assembly(GO:1902996) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.8 | 2.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.8 | 3.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.8 | 2.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.8 | 4.0 | GO:1902559 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.8 | 3.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.8 | 3.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.8 | 2.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.8 | 3.9 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.8 | 7.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.8 | 1.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.8 | 1.6 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.8 | 15.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.8 | 4.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.8 | 1.5 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.8 | 3.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.8 | 6.9 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.8 | 3.0 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.8 | 2.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.8 | 3.8 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.7 | 4.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.7 | 1.5 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.7 | 3.6 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.7 | 0.7 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.7 | 2.2 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.7 | 0.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.7 | 6.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 | 5.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.7 | 2.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.7 | 2.8 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.7 | 2.8 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.7 | 2.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.7 | 4.2 | GO:1904978 | regulation of endosome organization(GO:1904978) |
| 0.7 | 9.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.7 | 5.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.7 | 3.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.7 | 0.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.7 | 12.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.7 | 0.7 | GO:0032902 | nerve growth factor production(GO:0032902) |
| 0.7 | 6.9 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.7 | 8.2 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.7 | 2.0 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.7 | 4.1 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.7 | 0.7 | GO:0045007 | depurination(GO:0045007) |
| 0.7 | 2.0 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.7 | 2.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.7 | 4.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.7 | 3.3 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.7 | 1.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.7 | 3.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.7 | 5.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.7 | 5.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.7 | 7.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.7 | 0.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.7 | 3.9 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.7 | 1.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.7 | 0.7 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
| 0.7 | 1.3 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.7 | 0.7 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.7 | 3.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.7 | 5.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.6 | 0.6 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 0.6 | 5.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.6 | 11.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.6 | 1.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.6 | 1.9 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.6 | 10.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.6 | 1.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.6 | 7.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.6 | 4.4 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.6 | 2.5 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.6 | 4.4 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.6 | 1.9 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
| 0.6 | 3.1 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.6 | 1.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.6 | 4.4 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.6 | 8.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.6 | 1.9 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.6 | 3.7 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.6 | 1.9 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.6 | 7.9 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.6 | 1.8 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.6 | 2.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.6 | 1.8 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.6 | 1.8 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.6 | 5.4 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.6 | 4.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.6 | 1.8 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.6 | 1.8 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.6 | 0.6 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 0.6 | 2.9 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.6 | 1.7 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
| 0.6 | 2.3 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.6 | 1.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
| 0.6 | 1.7 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.6 | 4.0 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.6 | 4.0 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.6 | 1.1 | GO:1900166 | glial cell-derived neurotrophic factor secretion(GO:0044467) metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 0.6 | 5.7 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 | 1.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.6 | 0.6 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.6 | 1.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.6 | 1.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.6 | 2.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.6 | 1.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.6 | 0.6 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.6 | 11.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.6 | 0.6 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.6 | 1.7 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 0.6 | 2.2 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
| 0.6 | 1.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
| 0.6 | 2.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.6 | 9.9 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.5 | 1.6 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.5 | 2.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.5 | 0.5 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.5 | 1.6 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.5 | 1.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.5 | 1.6 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.5 | 2.2 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
| 0.5 | 1.6 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.5 | 1.6 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.5 | 3.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.5 | 1.6 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.5 | 3.8 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.5 | 2.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.5 | 1.6 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
| 0.5 | 1.6 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.5 | 0.5 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.5 | 1.6 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.5 | 2.1 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.5 | 2.7 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.5 | 2.7 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.5 | 1.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.5 | 1.6 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.5 | 6.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.5 | 3.2 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.5 | 3.2 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.5 | 2.6 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.5 | 1.6 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.5 | 1.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.5 | 1.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.5 | 2.1 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 2.1 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.5 | 1.6 | GO:0097502 | mannosylation(GO:0097502) |
| 0.5 | 19.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.5 | 1.6 | GO:0071931 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 0.5 | 1.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.5 | 4.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.5 | 2.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.5 | 2.6 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.5 | 1.5 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.5 | 3.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.5 | 2.0 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 | 1.0 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.5 | 1.5 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.5 | 3.0 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.5 | 2.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.5 | 2.5 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.5 | 3.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.5 | 2.5 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.5 | 1.0 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 1.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
| 0.5 | 0.5 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.5 | 1.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 7.5 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
| 0.5 | 1.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.5 | 1.5 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.5 | 1.5 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.5 | 1.5 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.5 | 16.8 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.5 | 1.0 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
| 0.5 | 2.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.5 | 1.5 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.5 | 0.5 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.5 | 2.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.5 | 2.0 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.5 | 3.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.5 | 7.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.5 | 1.0 | GO:0032763 | regulation of mast cell cytokine production(GO:0032763) |
| 0.5 | 3.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.5 | 1.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.5 | 4.3 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.5 | 1.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 | 5.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.5 | 4.8 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.5 | 1.9 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.5 | 1.4 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.5 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 0.5 | 1.9 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.5 | 1.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.5 | 1.4 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.5 | 1.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.5 | 5.2 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) |
| 0.5 | 3.8 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.5 | 3.3 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.5 | 0.5 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.5 | 0.9 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.5 | 0.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.5 | 0.9 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.5 | 2.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.5 | 2.3 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.5 | 1.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 0.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.5 | 2.3 | GO:0035645 | enteric smooth muscle cell differentiation(GO:0035645) |
| 0.5 | 1.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.5 | 1.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.5 | 0.9 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.5 | 1.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
| 0.5 | 0.9 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.5 | 1.4 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.5 | 8.7 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 | 5.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.5 | 3.2 | GO:0030421 | defecation(GO:0030421) |
| 0.5 | 0.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.5 | 5.0 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.5 | 1.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.5 | 2.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 3.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.5 | 7.7 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.5 | 1.4 | GO:0010933 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
| 0.5 | 1.4 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.5 | 3.6 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 0.5 | 0.9 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.4 | 10.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.4 | 4.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.4 | 2.2 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 | 0.4 | GO:0072011 | glomerular endothelium development(GO:0072011) |
| 0.4 | 3.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 | 1.8 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.4 | 4.0 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
| 0.4 | 0.9 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.4 | 2.7 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 | 1.3 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.4 | 2.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.4 | 2.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
| 0.4 | 0.9 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.4 | 1.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.4 | 3.9 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.4 | 3.0 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.4 | 6.1 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.4 | 9.9 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.4 | 3.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.4 | 0.4 | GO:1902822 | regulation of late endosome to lysosome transport(GO:1902822) positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.4 | 0.4 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
| 0.4 | 3.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.4 | 2.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.4 | 2.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 0.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.4 | 1.3 | GO:0035638 | patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.4 | 1.3 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.4 | 1.3 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.4 | 2.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.4 | 1.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 3.4 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 0.4 | 13.0 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.4 | 1.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.4 | 5.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.4 | 3.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.4 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.4 | 0.8 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 0.4 | 2.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.4 | 3.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.4 | 0.8 | GO:0042418 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.4 | 2.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.4 | 1.6 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 | 5.8 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.4 | 1.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.4 | 22.6 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.4 | 1.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.4 | 1.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.4 | 0.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 | 0.8 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.4 | 3.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.4 | 0.8 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.4 | 14.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.4 | 2.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 | 2.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.4 | 0.8 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.4 | 1.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.4 | 2.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.4 | 6.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.4 | 0.8 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.4 | 1.6 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.4 | 2.0 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.4 | 2.4 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.4 | 1.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.4 | 1.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.4 | 1.6 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.4 | 2.0 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.4 | 5.5 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.4 | 1.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.4 | 0.8 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
| 0.4 | 0.8 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.4 | 2.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 | 1.9 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.4 | 0.8 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
| 0.4 | 2.3 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.4 | 2.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.4 | 2.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.4 | 18.9 | GO:0007031 | peroxisome organization(GO:0007031) |
| 0.4 | 1.2 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.4 | 2.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.4 | 0.8 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.4 | 2.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.4 | 0.8 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 1.1 | GO:1904238 | kidney interstitial fibroblast differentiation(GO:0072071) pericyte cell differentiation(GO:1904238) |
| 0.4 | 1.1 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.4 | 0.8 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.4 | 1.1 | GO:1990426 | homologous recombination-dependent replication fork processing(GO:1990426) |
| 0.4 | 1.1 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.4 | 0.4 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.4 | 0.8 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.4 | 1.5 | GO:0021816 | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.4 | 4.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.4 | 1.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.4 | 2.6 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.4 | 3.7 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.4 | 0.7 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.4 | 1.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.4 | 0.7 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.4 | 1.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.4 | 1.1 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.4 | 0.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.4 | 1.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.4 | 0.4 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
| 0.4 | 2.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.4 | 1.1 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.4 | 1.1 | GO:0097274 | urea homeostasis(GO:0097274) |
| 0.4 | 1.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.4 | 2.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.4 | 0.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 0.4 | 3.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 2.5 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.4 | 0.7 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.4 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 0.4 | 1.4 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.4 | 1.8 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.4 | 1.8 | GO:0017085 | response to insecticide(GO:0017085) |
| 0.4 | 1.1 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
| 0.4 | 1.1 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.4 | 1.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.4 | 7.5 | GO:0072189 | ureter development(GO:0072189) |
| 0.4 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.4 | 1.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.4 | 1.1 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.4 | 2.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.4 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.4 | 1.1 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.4 | 0.7 | GO:0051458 | corticotropin secretion(GO:0051458) |
| 0.4 | 2.8 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.3 | 3.1 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.3 | 0.7 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.3 | 1.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 0.3 | 0.3 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 | 3.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 1.0 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.3 | 1.0 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.3 | 1.4 | GO:0018032 | protein amidation(GO:0018032) |
| 0.3 | 1.7 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 | 3.1 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.3 | 1.0 | GO:0051228 | mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 0.3 | 1.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.3 | 3.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.3 | 1.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 0.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.3 | 0.3 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
| 0.3 | 1.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.3 | 1.0 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.3 | 2.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.3 | 4.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.3 | 0.7 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.3 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.3 | 2.4 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.3 | 0.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.3 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.3 | 1.3 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.3 | 1.0 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.3 | 1.7 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.3 | 8.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 1.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.3 | 2.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.3 | 1.0 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.3 | 1.0 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
| 0.3 | 2.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 | 5.9 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.3 | 4.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.3 | 2.9 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.3 | 0.3 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.3 | 1.3 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.3 | 4.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.3 | 1.3 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.3 | 1.9 | GO:0021678 | third ventricle development(GO:0021678) |
| 0.3 | 2.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.3 | 1.0 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.3 | 1.0 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.3 | 1.6 | GO:0034036 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 | 1.9 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.3 | 1.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.3 | 1.0 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.3 | 1.3 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 | 1.3 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 | 5.4 | GO:0000050 | urea cycle(GO:0000050) |
| 0.3 | 0.9 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.3 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.3 | 0.6 | GO:2000584 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.3 | 1.9 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.3 | 1.9 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
| 0.3 | 1.9 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.3 | 35.5 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.3 | 0.6 | GO:0033123 | positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.3 | 6.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.3 | 6.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 | 1.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.3 | 1.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 | 2.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.3 | 5.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.3 | 0.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.3 | 1.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.3 | 0.9 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.3 | 0.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.3 | 1.8 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 | 5.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 0.9 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.3 | 0.9 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
| 0.3 | 1.8 | GO:0045914 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.3 | 3.6 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 | 0.3 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.3 | 2.4 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.3 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 | 0.6 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.3 | 2.7 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.3 | 0.3 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 0.3 | 1.2 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.3 | 1.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.3 | 0.3 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
| 0.3 | 1.2 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.3 | 0.3 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.3 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.3 | 2.4 | GO:0061744 | motor behavior(GO:0061744) |
| 0.3 | 1.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 0.6 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
| 0.3 | 0.6 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.3 | 0.9 | GO:0030047 | actin modification(GO:0030047) |
| 0.3 | 1.5 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.3 | 3.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 | 1.2 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.3 | 1.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 | 1.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
| 0.3 | 1.5 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.3 | 0.6 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.3 | 0.9 | GO:0060921 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.3 | 6.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 | 1.2 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.3 | 0.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.3 | 3.5 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.3 | 4.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 | 1.4 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 0.3 | 1.1 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.3 | 8.0 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.3 | 5.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.3 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.3 | 1.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 | 0.3 | GO:0045401 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.3 | 0.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.3 | 1.4 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 0.3 | 1.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 0.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.3 | 1.1 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.3 | 0.6 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.3 | 2.2 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.3 | 1.7 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.3 | 5.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.3 | 12.5 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.3 | 8.3 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.3 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 | 1.9 | GO:0015791 | polyol transport(GO:0015791) |
| 0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.3 | 0.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 0.3 | 12.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.3 | 2.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.3 | 1.1 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 | 0.8 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.3 | 0.5 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.3 | 0.8 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 | 1.9 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 1.4 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 0.5 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.3 | 2.2 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 | 1.1 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.3 | 1.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.3 | 1.9 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.3 | 2.4 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.3 | 0.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) positive regulation of somatostatin secretion(GO:0090274) |
| 0.3 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
| 0.3 | 1.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.3 | 0.8 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.3 | 1.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 | 0.3 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
| 0.3 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 0.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 | 1.1 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.3 | 2.6 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.3 | 1.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 | 2.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.3 | 6.8 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.3 | 5.0 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.3 | 5.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.3 | 0.5 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.3 | 3.6 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.3 | 2.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 | 1.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
| 0.3 | 5.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.3 | 0.5 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
| 0.3 | 0.5 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.3 | 1.3 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) |
| 0.3 | 0.8 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 0.3 | 2.0 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.3 | 0.8 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.3 | 0.8 | GO:0034183 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.3 | 0.8 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
| 0.3 | 0.8 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.3 | 0.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.3 | 0.5 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
| 0.3 | 0.5 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 | 4.8 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.3 | 0.8 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
| 0.3 | 0.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.3 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 1.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.3 | 5.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.3 | 1.0 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.3 | 1.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.2 | 0.7 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) |
| 0.2 | 4.2 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
| 0.2 | 1.0 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
| 0.2 | 1.5 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 | 1.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 | 1.0 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.2 | 2.5 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.2 | 1.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.2 | 2.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.2 | 2.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.2 | 4.6 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.2 | 1.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.2 | 2.7 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 1.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.2 | 1.2 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
| 0.2 | 1.0 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.2 | 6.8 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.2 | 5.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.2 | 0.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 2.2 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.2 | 2.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.5 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.2 | 2.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.2 | 1.2 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 | 2.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.2 | 1.0 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.2 | 0.7 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.2 | 1.0 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
| 0.2 | 0.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.2 | 1.2 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 0.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.2 | 3.8 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.2 | 0.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.2 | 1.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 | 1.2 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 0.2 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.2 | 2.1 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.2 | 0.5 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.2 | 2.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 | 0.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 0.2 | 0.7 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.2 | 1.2 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.2 | 0.2 | GO:0035759 | mesangial cell-matrix adhesion(GO:0035759) |
| 0.2 | 2.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 0.9 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.2 | 0.7 | GO:0001840 | neural plate development(GO:0001840) |
| 0.2 | 5.1 | GO:0060004 | reflex(GO:0060004) |
| 0.2 | 2.8 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.2 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
| 0.2 | 0.2 | GO:0072554 | blood vessel lumenization(GO:0072554) |
| 0.2 | 3.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 1.4 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.2 | 0.7 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.2 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.2 | 0.2 | GO:0071373 | cellular response to cocaine(GO:0071314) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.2 | 0.2 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.2 | 0.5 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.2 | 1.6 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.2 | 2.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 2.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.2 | 0.2 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate pattern specification(GO:0060896) neural plate regionalization(GO:0060897) |
| 0.2 | 0.4 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.2 | 0.7 | GO:0060032 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.2 | 4.0 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 | 0.4 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.2 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 0.4 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.2 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 | 0.9 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.2 | 2.4 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
| 0.2 | 1.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 0.2 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.2 | 1.1 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.2 | 1.5 | GO:0046929 | negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.2 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 1.7 | GO:0042262 | DNA protection(GO:0042262) |
| 0.2 | 1.1 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.2 | 4.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.2 | 1.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.2 | 0.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 1.5 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 1.1 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 2.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.2 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 0.2 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 0.2 | 1.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 0.8 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
| 0.2 | 0.6 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.2 | 0.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
| 0.2 | 0.6 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.2 | 1.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.2 | 0.4 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.2 | 1.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 | 0.2 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 0.2 | 2.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 | 1.2 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 | 2.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 | 2.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 1.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 | 1.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.2 | 2.0 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 0.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.2 | 0.2 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.2 | 0.4 | GO:0051135 | positive regulation of NK T cell activation(GO:0051135) |
| 0.2 | 0.6 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 | 1.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 0.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 | 0.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.2 | 1.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 | 0.6 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.2 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.2 | 0.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.2 | 0.8 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 | 1.6 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.2 | 0.2 | GO:0070989 | oxidative DNA demethylation(GO:0035511) oxidative demethylation(GO:0070989) |
| 0.2 | 1.4 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.2 | 2.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.2 | 0.8 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.2 | 1.4 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.2 | 1.4 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.2 | 0.4 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.2 | 0.6 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.2 | 4.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.2 | 2.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.2 | 0.8 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.2 | 0.4 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 7.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.2 | 2.7 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.2 | 1.3 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.2 | 1.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.2 | 1.0 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.2 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 0.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 | 0.4 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
| 0.2 | 0.9 | GO:0061741 | vacuolar transmembrane transport(GO:0034486) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) |
| 0.2 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.2 | 0.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.2 | 2.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.2 | 0.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.2 | 0.8 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.2 | 0.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 0.6 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.2 | 0.6 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.2 | 4.5 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.2 | 0.7 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 0.2 | 0.4 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.2 | 1.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 0.2 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 1.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 0.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 | 0.4 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.2 | 0.2 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
| 0.2 | 0.4 | GO:0035564 | regulation of kidney size(GO:0035564) |
| 0.2 | 2.2 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.2 | 0.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.2 | 0.5 | GO:0002884 | negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.2 | 0.4 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
| 0.2 | 0.4 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 0.2 | 1.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.2 | 3.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.2 | 0.7 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 1.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.2 | 1.2 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 | 1.1 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.2 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.2 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.2 | 0.5 | GO:0035844 | cloaca development(GO:0035844) |
| 0.2 | 0.4 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.2 | 1.2 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.2 | 0.5 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.2 | 0.4 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.2 | 1.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
| 0.2 | 0.2 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.2 | 0.9 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.2 | 0.2 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.2 | 5.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 1.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.2 | 3.0 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.2 | 0.2 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.2 | 1.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 | 2.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.2 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.2 | 1.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.2 | 0.7 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 0.2 | 0.3 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
| 0.2 | 0.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.2 | 0.7 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.2 | 1.2 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
| 0.2 | 2.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.2 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.2 | 2.0 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.2 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 0.7 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.2 | 1.1 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.2 | 0.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 | 0.8 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.2 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.2 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 1.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 1.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.2 | 1.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.2 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 0.5 | GO:0035691 | macrophage migration inhibitory factor signaling pathway(GO:0035691) |
| 0.2 | 0.8 | GO:0015853 | adenine transport(GO:0015853) |
| 0.2 | 3.2 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.2 | 5.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.2 | 4.3 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
| 0.2 | 0.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 | 0.5 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.2 | 1.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
| 0.2 | 0.8 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.2 | 2.0 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 | 1.3 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.2 | 0.6 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
| 0.2 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.2 | 0.2 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.2 | 3.7 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.2 | 0.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.2 | 1.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.3 | GO:0072710 | response to hydroxyurea(GO:0072710) |
| 0.2 | 0.3 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.2 | 1.8 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.2 | 0.6 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.2 | 1.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.2 | 0.8 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.2 | 0.3 | GO:0072537 | fibroblast activation(GO:0072537) |
| 0.2 | 0.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 0.2 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
| 0.2 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 | 0.5 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 1.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 | 1.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 0.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 | 1.0 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.1 | 0.4 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.1 | 1.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 1.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 3.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 | 1.5 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 0.3 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 | 6.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 0.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.1 | 2.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 1.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.1 | 0.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.1 | 0.6 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.1 | 1.4 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.1 | 3.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.1 | 5.3 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 0.6 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.1 | 0.4 | GO:0006563 | L-serine metabolic process(GO:0006563) |
| 0.1 | 0.3 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.1 | 0.9 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.1 | 26.5 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 2.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.1 | 1.8 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.3 | GO:2000909 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.1 | 0.4 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.1 | 0.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 | 2.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 1.8 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.7 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 1.2 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 | 1.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 | 0.7 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 | 0.3 | GO:0071874 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 4.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 4.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.1 | 5.4 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.7 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 0.1 | 15.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 1.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.5 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.1 | 0.8 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.1 | 0.1 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.1 | 0.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.1 | 0.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.1 | 0.8 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.1 | 0.3 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.1 | 0.4 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 | 0.1 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.1 | 0.7 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 | 2.6 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.4 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 1.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.1 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.5 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 | 1.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.6 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.1 | 1.3 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.1 | 1.3 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 | 3.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.1 | 4.7 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 0.6 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.1 | 0.9 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.1 | 0.3 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 2.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.6 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.1 | 0.4 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 | 0.4 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
| 0.1 | 0.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 1.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.6 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 0.2 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.1 | 1.0 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 0.1 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 4.3 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 1.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.4 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.1 | 1.0 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
| 0.1 | 0.6 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.1 | 0.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.1 | 0.2 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 | 1.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
| 0.1 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 | 2.6 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 0.1 | 1.2 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.1 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 | 0.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
| 0.1 | 0.6 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.1 | 0.1 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 | 0.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.1 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.1 | 0.9 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 | 0.9 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 0.3 | GO:2000481 | negative regulation of melanin biosynthetic process(GO:0048022) dendritic cell apoptotic process(GO:0097048) negative regulation of secondary metabolite biosynthetic process(GO:1900377) positive regulation of cAMP-dependent protein kinase activity(GO:2000481) regulation of dendritic cell apoptotic process(GO:2000668) positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 | 0.3 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.5 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.1 | 0.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.1 | 0.3 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
| 0.1 | 0.7 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.1 | 1.1 | GO:0010452 | regulation of histone H3-K36 methylation(GO:0000414) histone H3-K36 methylation(GO:0010452) |
| 0.1 | 0.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 0.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
| 0.1 | 0.1 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.1 | 0.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.1 | 0.7 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 | 1.1 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
| 0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.1 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.1 | 1.8 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
| 0.1 | 1.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 2.0 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 | 0.6 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 | 3.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 1.3 | GO:0097009 | energy homeostasis(GO:0097009) |
| 0.1 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.1 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
| 0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.3 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 | 0.6 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.1 | 0.7 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.1 | 1.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.1 | 0.1 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 0.2 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.1 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.1 | 1.3 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.1 | 0.2 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.1 | 1.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.1 | 0.2 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 | 2.4 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.1 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.1 | 1.4 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 0.3 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.1 | 1.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.3 | GO:0061110 | dense core granule biogenesis(GO:0061110) amniotic stem cell differentiation(GO:0097086) regulation of dense core granule biogenesis(GO:2000705) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.1 | 2.2 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 | 1.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 3.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.3 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 0.3 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
| 0.1 | 0.2 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.1 | 0.6 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 | 0.2 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.1 | 0.4 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 3.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.1 | 0.2 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 | 0.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 0.1 | 1.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 1.3 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.5 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 | 0.1 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.1 | 1.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.2 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.2 | GO:0071599 | otic vesicle development(GO:0071599) |
| 0.1 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.1 | 0.9 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.1 | 0.2 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.1 | 0.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 | 0.6 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.1 | 0.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.1 | 0.4 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.1 | 1.8 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 | 0.4 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 0.4 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 | 4.1 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 | 0.2 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 2.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 | 0.9 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.1 | 0.2 | GO:0042363 | fat-soluble vitamin catabolic process(GO:0042363) |
| 0.1 | 0.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
| 0.1 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 | 0.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 | 1.2 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.1 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.1 | 0.2 | GO:0050928 | Tie signaling pathway(GO:0048014) negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 | 0.5 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 10.9 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
| 0.1 | 0.7 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 | 0.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.8 | GO:0071313 | response to caffeine(GO:0031000) cellular response to caffeine(GO:0071313) |
| 0.1 | 0.2 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 | 1.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 | 1.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 | 0.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 | 0.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 0.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 | 0.2 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 | 0.5 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 0.8 | GO:0006414 | translational elongation(GO:0006414) |
| 0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.1 | 0.8 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.4 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.1 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.6 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 | 0.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 0.1 | 0.7 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
| 0.1 | 2.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.1 | 4.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.1 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 7.4 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.1 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.9 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
| 0.1 | 0.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 0.1 | 7.1 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 | 1.6 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.3 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
| 0.1 | 0.2 | GO:0046072 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.1 | 0.3 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.1 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 0.1 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 | 1.0 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.8 | GO:0014029 | neural crest formation(GO:0014029) |
| 0.1 | 0.3 | GO:0010734 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 0.1 | 0.4 | GO:0006312 | mitotic recombination(GO:0006312) |
| 0.1 | 0.6 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
| 0.1 | 0.2 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 2.5 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 | 0.9 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 | 0.1 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.1 | 0.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.7 | GO:0075713 | establishment of integrated proviral latency(GO:0075713) |
| 0.1 | 0.4 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.6 | GO:1901660 | calcium ion export(GO:1901660) |
| 0.1 | 0.7 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
| 0.1 | 1.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.1 | 1.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 | 0.2 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
| 0.1 | 0.4 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.1 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.9 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 | 0.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.1 | 0.9 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.2 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 0.8 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 2.4 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.1 | 0.3 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.1 | 1.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 | 0.2 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
| 0.1 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 0.1 | 0.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 | 0.4 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 | 0.5 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 1.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 2.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 0.2 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
| 0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.3 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.1 | 1.6 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.1 | 0.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.0 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.7 | GO:0006298 | mismatch repair(GO:0006298) |
| 0.0 | 0.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.0 | 0.2 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.0 | 0.4 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.0 | 1.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.0 | 0.4 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.0 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 0.0 | 5.5 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 0.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
| 0.0 | 0.2 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.3 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.0 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.0 | 0.1 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
| 0.0 | 0.1 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.0 | 0.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.2 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.0 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 | 0.0 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.0 | 0.4 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.0 | 0.4 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
| 0.0 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 | 1.0 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 | 0.0 | GO:0002396 | MHC protein complex assembly(GO:0002396) |
| 0.0 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
| 0.0 | 0.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.0 | 0.0 | GO:0060437 | lung growth(GO:0060437) |
| 0.0 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.0 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 0.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.0 | 0.2 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
| 0.0 | 0.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.0 | 0.1 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.0 | 0.6 | GO:0006415 | translational termination(GO:0006415) |
| 0.0 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
| 0.0 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.1 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
| 0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.0 | 0.1 | GO:0042461 | photoreceptor cell development(GO:0042461) |
| 0.0 | 0.0 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.0 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
| 0.0 | 0.1 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.0 | 0.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 | 0.4 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.0 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 | 0.1 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
| 0.0 | 0.7 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
| 0.0 | 0.1 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 0.2 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.0 | 0.3 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.0 | 0.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 0.0 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
| 0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 | 0.0 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.0 | 0.1 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
| 0.0 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 | 0.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.0 | 0.3 | GO:0021860 | pyramidal neuron development(GO:0021860) |
| 0.0 | 0.0 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.0 | 0.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 | 0.1 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 | 0.5 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.0 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) regulation of nonmotile primary cilium assembly(GO:1902855) |
| 0.0 | 0.2 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.0 | 0.2 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.0 | 0.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 0.8 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.0 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.3 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.2 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.0 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.0 | 0.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.0 | GO:1902688 | regulation of NAD metabolic process(GO:1902688) |
| 0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.0 | 0.2 | GO:1903170 | negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 0.0 | 0.0 | GO:0051029 | rRNA transport(GO:0051029) |
| 0.0 | 0.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.0 | 0.7 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.0 | 0.1 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.0 | 0.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.0 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
| 0.0 | 0.1 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
| 0.0 | 0.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.0 | 0.1 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.0 | 0.1 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.0 | 0.0 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 | 0.4 | GO:0001754 | eye photoreceptor cell differentiation(GO:0001754) |
| 0.0 | 0.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 | 0.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.0 | 0.0 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.0 | 0.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.0 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 0.0 | 0.1 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.0 | 0.0 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 19.4 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 1.8 | 9.0 | GO:0032449 | CBM complex(GO:0032449) |
| 1.7 | 8.3 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 1.5 | 7.6 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 1.4 | 5.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 1.3 | 6.3 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.2 | 5.0 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 1.1 | 6.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.1 | 3.2 | GO:0031251 | PAN complex(GO:0031251) |
| 1.0 | 1.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 1.0 | 3.1 | GO:0043293 | apoptosome(GO:0043293) |
| 1.0 | 13.9 | GO:0034464 | BBSome(GO:0034464) |
| 1.0 | 2.9 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.0 | 7.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.0 | 4.8 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.9 | 9.1 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.9 | 3.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.9 | 5.3 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.9 | 4.4 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.9 | 2.6 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.8 | 2.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.8 | 5.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.8 | 1.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.8 | 2.4 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.7 | 6.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.7 | 8.1 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.7 | 2.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.7 | 2.9 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.7 | 2.8 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.7 | 7.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.7 | 7.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.7 | 5.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.7 | 2.7 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.7 | 6.0 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.6 | 1.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.6 | 1.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.6 | 4.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.6 | 3.7 | GO:1990357 | terminal web(GO:1990357) |
| 0.6 | 2.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.6 | 1.8 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.6 | 6.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.6 | 4.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.6 | 1.2 | GO:0043260 | laminin-11 complex(GO:0043260) |
| 0.6 | 1.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.6 | 1.7 | GO:0071752 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 0.6 | 2.3 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.6 | 4.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.6 | 4.6 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.6 | 2.9 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.6 | 1.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.6 | 12.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.6 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
| 0.5 | 3.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.5 | 2.7 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.5 | 2.7 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.5 | 5.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.5 | 2.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.5 | 35.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.5 | 0.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.5 | 1.6 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.5 | 3.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.5 | 3.6 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.5 | 13.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.5 | 2.5 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.5 | 4.0 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.5 | 1.5 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.5 | 0.5 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.5 | 0.5 | GO:0071751 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.5 | 2.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.5 | 1.9 | GO:0097196 | Shu complex(GO:0097196) |
| 0.5 | 1.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.5 | 5.8 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.5 | 4.2 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.5 | 0.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.5 | 7.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.5 | 1.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.5 | 11.7 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.5 | 5.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.4 | 1.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.4 | 2.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.4 | 4.8 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 0.9 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 17.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.4 | 18.4 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.4 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.4 | 1.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.4 | 2.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.4 | 3.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.4 | 0.8 | GO:0055087 | Ski complex(GO:0055087) |
| 0.4 | 1.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.4 | 3.3 | GO:0000796 | condensin complex(GO:0000796) |
| 0.4 | 3.3 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.4 | 1.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.4 | 8.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.4 | 1.6 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.4 | 0.8 | GO:0044308 | axonal spine(GO:0044308) |
| 0.4 | 12.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.4 | 0.8 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.4 | 1.2 | GO:1905103 | integral component of lysosomal membrane(GO:1905103) |
| 0.4 | 2.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.4 | 7.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.4 | 3.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.4 | 5.8 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.4 | 1.1 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.4 | 25.3 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.4 | 1.5 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.4 | 0.7 | GO:0097179 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) protease inhibitor complex(GO:0097179) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.4 | 2.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.4 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.4 | 2.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.4 | 3.3 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.4 | 7.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.4 | 2.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.4 | 4.4 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.4 | 2.5 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.4 | 4.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.4 | 1.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.4 | 28.5 | GO:0045095 | keratin filament(GO:0045095) |
| 0.4 | 14.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.4 | 2.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.4 | 0.4 | GO:0005816 | spindle pole body(GO:0005816) |
| 0.4 | 5.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 6.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.3 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.3 | 4.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.3 | 5.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.3 | 9.4 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.3 | 3.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.3 | 6.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 1.0 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.3 | 6.6 | GO:0031045 | dense core granule(GO:0031045) |
| 0.3 | 3.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.3 | 1.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.3 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
| 0.3 | 1.3 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.3 | 2.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.3 | 1.0 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.3 | 1.0 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 1.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 0.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.3 | 7.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.3 | 5.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.3 | 18.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 0.3 | GO:1990462 | omegasome(GO:1990462) |
| 0.3 | 4.9 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.3 | 1.8 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.3 | 2.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.3 | 18.5 | GO:0031430 | M band(GO:0031430) |
| 0.3 | 0.6 | GO:0000805 | X chromosome(GO:0000805) |
| 0.3 | 0.9 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.3 | 4.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 3.7 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.3 | 2.0 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 3.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.3 | 2.2 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 2.5 | GO:0016012 | sarcoglycan complex(GO:0016012) |
| 0.3 | 4.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
| 0.3 | 1.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.3 | 0.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.3 | 1.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.3 | 4.0 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 2.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.3 | 1.9 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.3 | 2.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.3 | 1.6 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.3 | 2.4 | GO:0071546 | pi-body(GO:0071546) |
| 0.3 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
| 0.3 | 5.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.3 | 0.8 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.3 | 5.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.3 | 0.8 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.3 | 0.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.2 | 2.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 2.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.2 | 1.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.2 | 0.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.2 | 1.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.2 | 2.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.2 | 6.1 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 0.5 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.2 | 1.0 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.2 | 0.2 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
| 0.2 | 2.1 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.2 | 15.4 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
| 0.2 | 0.9 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.2 | 1.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.2 | 2.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.2 | 3.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 2.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.2 | 1.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.2 | 1.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 33.1 | GO:0005814 | centriole(GO:0005814) |
| 0.2 | 1.3 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.2 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 1.1 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.2 | 1.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 1.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.2 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.2 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 1.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.2 | 1.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.2 | 7.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.2 | 3.4 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 0.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 8.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.2 | 1.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.2 | 3.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.2 | 1.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.2 | 1.6 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.2 | 3.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 2.4 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.2 | 2.8 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 1.6 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.2 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.2 | 5.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.2 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.2 | 0.6 | GO:0071920 | cleavage body(GO:0071920) |
| 0.2 | 5.3 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.2 | 5.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.2 | 6.4 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.2 | 0.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.2 | 0.9 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.2 | 16.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 3.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.2 | 0.4 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.2 | 0.5 | GO:0097545 | axonemal outer doublet(GO:0097545) |
| 0.2 | 2.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 0.7 | GO:0032009 | early phagosome(GO:0032009) |
| 0.2 | 3.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.2 | 0.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.2 | 4.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 1.2 | GO:0008091 | spectrin(GO:0008091) |
| 0.2 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 3.9 | GO:0031672 | A band(GO:0031672) |
| 0.2 | 2.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 2.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.2 | 19.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 0.5 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.2 | 2.2 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.2 | 0.5 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.2 | 2.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.2 | 2.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.2 | 0.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.2 | 1.0 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.2 | 4.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.2 | 0.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 2.6 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.2 | 1.0 | GO:0031417 | NatC complex(GO:0031417) |
| 0.2 | 4.0 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 3.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 1.6 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.2 | 2.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.2 | 2.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.2 | 7.6 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 0.6 | GO:0019034 | viral replication complex(GO:0019034) |
| 0.2 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 1.7 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.2 | 0.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.2 | 1.7 | GO:0097433 | dense body(GO:0097433) |
| 0.2 | 5.0 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.2 | 1.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.2 | 1.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 0.6 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.1 | 3.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.1 | 2.5 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 1.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.1 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.1 | 0.9 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.1 | 2.4 | GO:0044815 | DNA packaging complex(GO:0044815) |
| 0.1 | 18.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 2.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.1 | 20.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 6.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 2.0 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.2 | GO:0030990 | intraciliary transport particle(GO:0030990) |
| 0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.4 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
| 0.1 | 1.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.1 | 9.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.5 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.1 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 1.2 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.5 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 5.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 0.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.1 | 1.4 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 7.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.1 | 0.4 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 2.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.1 | 0.5 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 0.6 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 1.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 1.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 3.7 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 2.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.3 | GO:0033167 | ARC complex(GO:0033167) |
| 0.1 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.4 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.1 | 1.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.1 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.8 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.1 | 10.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.1 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 1.8 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 1.0 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.1 | 1.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 5.0 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 1.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 0.9 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 0.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 0.5 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.1 | 10.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 5.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.1 | 2.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.1 | 6.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 1.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 3.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 2.7 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.1 | 1.6 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 0.6 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 4.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.1 | 1.1 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 15.7 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
| 0.1 | 0.3 | GO:0032116 | SMC loading complex(GO:0032116) |
| 0.1 | 1.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 0.2 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.1 | 34.1 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 2.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 0.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 0.1 | 5.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.1 | 0.5 | GO:0034448 | EGO complex(GO:0034448) |
| 0.1 | 0.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 1.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 2.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 5.5 | GO:0031248 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
| 0.1 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 9.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.1 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 5.3 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.4 | GO:0030894 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
| 0.1 | 1.0 | GO:0035859 | Seh1-associated complex(GO:0035859) |
| 0.1 | 5.0 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 3.5 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 5.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 4.1 | GO:0005901 | caveola(GO:0005901) |
| 0.1 | 0.1 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 1.6 | GO:0055029 | nuclear DNA-directed RNA polymerase complex(GO:0055029) |
| 0.1 | 22.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.1 | 1.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.5 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 4.0 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 2.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.1 | 0.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.1 | 3.2 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.0 | 4.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.0 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.0 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.0 | 3.4 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 1.9 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.0 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.6 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.0 | 0.4 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.0 | 0.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 0.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.0 | 0.1 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.0 | 0.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.0 | 1.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.2 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.0 | 0.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.0 | 0.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
| 0.0 | 0.1 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.0 | 0.4 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.1 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.0 | 0.1 | GO:0002177 | manchette(GO:0002177) |
| 0.0 | 0.8 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.0 | 0.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.0 | 0.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.0 | GO:1990742 | microvesicle(GO:1990742) |
| 0.0 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.8 | 11.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 2.4 | 9.6 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 2.3 | 11.4 | GO:0003896 | DNA primase activity(GO:0003896) |
| 2.1 | 6.2 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.9 | 9.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 1.9 | 15.4 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.9 | 14.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.8 | 7.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.8 | 5.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 1.8 | 5.3 | GO:0003860 | 3-hydroxyisobutyryl-CoA hydrolase activity(GO:0003860) |
| 1.6 | 9.8 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 1.6 | 9.7 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 1.6 | 6.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.6 | 9.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 1.5 | 6.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 1.5 | 7.6 | GO:0000406 | double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 1.5 | 4.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 1.5 | 6.0 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 1.5 | 1.5 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 1.4 | 5.8 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 1.4 | 7.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 1.4 | 1.4 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 1.4 | 4.1 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 1.4 | 4.1 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.4 | 4.1 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.3 | 10.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 1.3 | 4.0 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 1.3 | 10.6 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 1.3 | 4.0 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.3 | 9.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 1.3 | 10.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 1.2 | 5.0 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 1.2 | 19.8 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 1.2 | 8.6 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 1.2 | 7.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.2 | 3.6 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 1.2 | 8.3 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 1.2 | 4.7 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 1.2 | 3.5 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 1.1 | 3.4 | GO:0036055 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 1.1 | 3.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.1 | 3.4 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 1.1 | 4.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 1.1 | 4.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.1 | 3.2 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 1.1 | 4.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 1.0 | 7.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 1.0 | 16.6 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 1.0 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.0 | 4.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.0 | 4.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.0 | 3.0 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 1.0 | 1.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 1.0 | 2.0 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 1.0 | 3.0 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 1.0 | 7.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.0 | 4.8 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 1.0 | 1.9 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.9 | 11.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.9 | 2.8 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.9 | 3.7 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
| 0.9 | 1.9 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.9 | 2.8 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.9 | 2.8 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.9 | 2.7 | GO:0008893 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.9 | 8.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.9 | 6.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.9 | 3.5 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.9 | 4.3 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.9 | 2.6 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.9 | 2.6 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
| 0.9 | 1.7 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
| 0.8 | 2.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.8 | 2.5 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.8 | 2.5 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.8 | 4.1 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.8 | 4.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.8 | 10.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.8 | 2.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.8 | 0.8 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.8 | 8.0 | GO:0071253 | connexin binding(GO:0071253) |
| 0.8 | 4.0 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.8 | 3.2 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.8 | 4.0 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.8 | 3.2 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.8 | 3.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.8 | 2.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.8 | 11.0 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.8 | 2.4 | GO:0044713 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 0.8 | 3.9 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.8 | 2.4 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.8 | 3.1 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.8 | 2.3 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.8 | 6.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.7 | 5.9 | GO:0015923 | mannosidase activity(GO:0015923) |
| 0.7 | 2.2 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.7 | 8.7 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.7 | 4.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.7 | 3.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.7 | 2.2 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.7 | 5.0 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.7 | 2.8 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 0.7 | 7.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.7 | 3.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.7 | 0.7 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.7 | 13.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.7 | 4.8 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.7 | 2.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.7 | 2.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.7 | 0.7 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.7 | 2.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.7 | 2.0 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.7 | 2.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.7 | 3.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.7 | 3.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.7 | 2.0 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.7 | 1.3 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 0.7 | 7.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.7 | 3.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.6 | 1.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.6 | 7.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.6 | 1.9 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.6 | 1.9 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.6 | 0.6 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.6 | 4.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.6 | 0.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.6 | 3.2 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.6 | 2.5 | GO:0070404 | NADH binding(GO:0070404) |
| 0.6 | 3.8 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.6 | 1.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.6 | 1.9 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.6 | 8.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.6 | 0.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.6 | 2.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.6 | 1.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.6 | 4.3 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.6 | 3.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.6 | 3.7 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.6 | 1.8 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.6 | 1.2 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.6 | 5.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.6 | 3.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.6 | 3.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.6 | 3.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.6 | 1.8 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.6 | 9.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.6 | 5.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.6 | 1.7 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.6 | 9.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.6 | 2.9 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.6 | 2.9 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.6 | 2.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.6 | 9.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.6 | 3.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.6 | 1.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.6 | 2.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.6 | 1.7 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.6 | 3.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.6 | 2.2 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.6 | 20.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.5 | 2.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.5 | 1.6 | GO:0061599 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.5 | 2.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.5 | 8.1 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 0.5 | 2.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.5 | 2.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.5 | 1.6 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.5 | 2.1 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 0.5 | 1.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.5 | 3.2 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.5 | 3.2 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.5 | 2.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.5 | 1.6 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.5 | 5.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.5 | 2.1 | GO:0009374 | biotin binding(GO:0009374) |
| 0.5 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.5 | 20.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.5 | 1.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.5 | 3.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 4.6 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.5 | 2.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.5 | 2.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.5 | 2.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.5 | 2.0 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 0.5 | 1.5 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.5 | 4.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.5 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.5 | 2.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.5 | 1.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.5 | 10.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.5 | 1.5 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.5 | 1.0 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.5 | 1.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.5 | 1.5 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.5 | 5.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.5 | 1.4 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.5 | 2.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.5 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.5 | 1.9 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.5 | 2.3 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 0.5 | 0.5 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.5 | 5.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.5 | 4.2 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 4.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.5 | 4.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.5 | 3.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.5 | 1.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.5 | 1.4 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
| 0.4 | 1.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.4 | 0.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.4 | 3.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.4 | 3.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.4 | 3.1 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 1.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.4 | 4.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.4 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.4 | 2.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.4 | 2.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.4 | 3.5 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.4 | 2.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.4 | 1.7 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.4 | 4.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.4 | 0.4 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.4 | 4.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.4 | 2.6 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.4 | 1.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.4 | 4.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.4 | 1.7 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.4 | 7.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.4 | 1.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.4 | 14.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.4 | 1.7 | GO:0005534 | galactose binding(GO:0005534) |
| 0.4 | 4.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.4 | 1.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.4 | 0.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.4 | 2.5 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 2.0 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.4 | 2.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.4 | 1.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.4 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.4 | 2.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.4 | 6.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.4 | 1.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
| 0.4 | 4.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 5.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.4 | 9.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.4 | 1.2 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.4 | 2.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.4 | 1.5 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.4 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.4 | 1.2 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.4 | 3.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.4 | 1.9 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 2.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.4 | 1.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.4 | 2.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.4 | 1.5 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.4 | 1.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.4 | 3.7 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.4 | 3.0 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.4 | 0.4 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.4 | 3.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.4 | 1.1 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 0.4 | 0.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.4 | 6.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.4 | 4.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.4 | 1.8 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 0.4 | 1.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.4 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
| 0.4 | 1.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.4 | 2.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.4 | 0.7 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.4 | 5.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.4 | 10.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 2.1 | GO:0016807 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.4 | 1.4 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
| 0.4 | 1.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.4 | 1.1 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.4 | 5.6 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.3 | 2.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 3.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 0.3 | 2.4 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 0.3 | 1.0 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.3 | 1.4 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.3 | 0.7 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.3 | 9.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.3 | 3.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
| 0.3 | 1.4 | GO:0070905 | serine binding(GO:0070905) |
| 0.3 | 1.0 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.3 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.3 | 1.7 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.3 | 2.7 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.3 | 1.4 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 0.3 | 1.7 | GO:0089720 | caspase binding(GO:0089720) |
| 0.3 | 1.3 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.3 | 3.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.3 | 1.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.3 | 4.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.3 | 0.3 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.3 | 1.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.3 | 2.0 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.3 | 1.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 0.3 | 2.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.3 | 3.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 1.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 3.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.3 | 1.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.3 | 1.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.3 | 1.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.3 | 2.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.3 | 1.6 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.3 | 0.3 | GO:0032404 | mismatch repair complex binding(GO:0032404) |
| 0.3 | 2.2 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.3 | 8.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.3 | 5.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.3 | 0.9 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.3 | 1.5 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.3 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.3 | 0.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.3 | 2.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 1.8 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.3 | 2.7 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 0.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.3 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.3 | 1.2 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.3 | 0.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 0.9 | GO:0004639 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.3 | 3.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.3 | 3.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.3 | 0.3 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 0.3 | 1.8 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 0.9 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.3 | 0.9 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.3 | 2.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.3 | 0.9 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 0.3 | 8.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.3 | 1.1 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.3 | 2.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.3 | 0.9 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.3 | 9.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.3 | 4.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.3 | 0.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.3 | 1.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.3 | 1.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.3 | 1.1 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.3 | 0.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 0.8 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 0.3 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.3 | 1.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.3 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.3 | 2.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.3 | 0.5 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.3 | 0.3 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.3 | 4.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.3 | 1.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 4.3 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.3 | 1.1 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.3 | 7.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.3 | 0.8 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.3 | 5.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.3 | 3.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.3 | 0.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 1.3 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 2.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.3 | 6.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.3 | 2.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.3 | 0.8 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.3 | 6.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 4.5 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.3 | 2.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.3 | 1.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.3 | 0.3 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.3 | 3.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 0.3 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
| 0.3 | 5.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 0.8 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.3 | 0.8 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.3 | 2.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.3 | 1.3 | GO:0052794 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.3 | 0.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.3 | 1.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.3 | 1.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 1.3 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.3 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 2.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.3 | 1.5 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 0.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 3.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 1.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.2 | 5.2 | GO:0001083 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.2 | 1.5 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 0.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 1.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.2 | 2.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.2 | 2.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 2.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.2 | 2.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 14.5 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 2.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 2.1 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 0.5 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.2 | 0.9 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.2 | 4.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 5.7 | GO:0031432 | titin binding(GO:0031432) |
| 0.2 | 1.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.2 | 0.9 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
| 0.2 | 0.2 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 0.9 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.2 | 1.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.2 | 1.6 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 5.0 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
| 0.2 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 1.3 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.2 | 3.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 0.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 0.2 | 0.6 | GO:0019777 | Atg12 transferase activity(GO:0019777) |
| 0.2 | 1.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 1.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 0.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.2 | 1.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.2 | 6.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.2 | 1.9 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.2 | 6.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.2 | 0.8 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.2 | 1.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.2 | 2.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.2 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.2 | 2.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.2 | 1.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.2 | 0.8 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.2 | 1.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.2 | 0.6 | GO:0035375 | zymogen binding(GO:0035375) |
| 0.2 | 1.0 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.2 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 4.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 0.6 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 0.2 | 0.8 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 0.2 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.2 | 1.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.2 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.2 | 6.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 6.8 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.2 | 1.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 2.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.2 | 2.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 2.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.2 | 0.2 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.2 | 1.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 0.6 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 1.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 1.0 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 4.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.2 | 3.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 0.2 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) |
| 0.2 | 0.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 6.6 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 0.6 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 0.2 | 0.7 | GO:0035276 | ethanol binding(GO:0035276) |
| 0.2 | 0.9 | GO:0004096 | catalase activity(GO:0004096) |
| 0.2 | 0.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.2 | 1.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 1.6 | GO:0008430 | selenium binding(GO:0008430) |
| 0.2 | 7.5 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.2 | 0.4 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
| 0.2 | 1.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 2.0 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 0.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.2 | 7.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.2 | 1.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.2 | 0.5 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.2 | 4.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.2 | 5.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.2 | 2.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.2 | 0.5 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
| 0.2 | 1.4 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.2 | 0.5 | GO:0052830 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.2 | 3.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.2 | 7.5 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.2 | 0.5 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 1.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.2 | 0.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 2.0 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.2 | 2.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.2 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.2 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.2 | 0.3 | GO:0000035 | acyl binding(GO:0000035) |
| 0.2 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.2 | 3.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
| 0.2 | 1.1 | GO:0097617 | RNA strand annealing activity(GO:0033592) annealing activity(GO:0097617) |
| 0.2 | 0.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 1.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 1.0 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 7.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 0.3 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.2 | 12.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.2 | 3.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 1.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 3.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.2 | 0.2 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 1.3 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 1.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.2 | 4.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 0.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.2 | 3.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.2 | 2.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 0.6 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.2 | 0.8 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.2 | 2.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 0.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 4.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 1.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 6.1 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.1 | 3.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.1 | 0.7 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.1 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.1 | 0.1 | GO:0005119 | smoothened binding(GO:0005119) |
| 0.1 | 1.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
| 0.1 | 0.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.1 | 0.6 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 0.1 | 2.7 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 3.4 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 0.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 4.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 1.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.4 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.1 | 0.1 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.1 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.1 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.1 | 1.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 0.3 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 0.1 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
| 0.1 | 0.7 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.1 | 0.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 1.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 3.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.1 | 0.5 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.1 | 0.4 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 6.5 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.1 | 4.0 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.1 | 0.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.1 | 30.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.1 | 16.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 1.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 2.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.9 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 0.9 | GO:0071949 | FAD binding(GO:0071949) |
| 0.1 | 0.5 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.5 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.1 | 2.2 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 1.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 0.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 2.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
| 0.1 | 1.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.1 | 1.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.1 | 2.1 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 1.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 10.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 1.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.4 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
| 0.1 | 0.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 2.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 3.7 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 1.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 1.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.1 | 0.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.1 | 5.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.1 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 0.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 6.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 5.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 1.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.1 | 1.2 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.1 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 1.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 5.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 2.1 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 1.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.1 | 1.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.1 | 7.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 5.3 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.1 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.1 | 0.6 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.1 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 0.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.1 | 3.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.8 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.1 | 2.6 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 3.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 1.3 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
| 0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 0.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.1 | 21.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 5.7 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 0.4 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 1.7 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 0.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.1 | 0.4 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 0.5 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
| 0.1 | 0.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.1 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.1 | 3.4 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.1 | 1.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.1 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.5 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.1 | 0.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 0.6 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 5.3 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.1 | 1.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.1 | 0.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.1 | 0.1 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.1 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 5.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.2 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.1 | 1.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.1 | 1.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
| 0.1 | 1.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 0.1 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.1 | 1.0 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 2.7 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.2 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 1.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 1.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 2.3 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.1 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.6 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 0.1 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.2 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.1 | 0.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.1 | 6.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 0.2 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) |
| 0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 4.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 0.3 | GO:0030622 | U4atac snRNA binding(GO:0030622) |
| 0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 0.6 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.4 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 1.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.1 | 0.7 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
| 0.1 | 0.1 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.1 | 0.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
| 0.1 | 0.2 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.1 | 0.1 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
| 0.1 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.1 | 0.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.1 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 7.2 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
| 0.1 | 0.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.8 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.1 | 0.7 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
| 0.1 | 2.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.1 | 0.3 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 0.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.0 | 0.1 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
| 0.0 | 0.1 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.0 | 7.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.0 | 1.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.6 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
| 0.0 | 1.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.4 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 0.2 | GO:0000829 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.0 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.0 | 0.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.0 | 0.1 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.0 | 3.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.0 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.0 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.0 | 0.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.0 | 1.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.4 | GO:0019841 | retinol binding(GO:0019841) |
| 0.0 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.0 | 6.4 | GO:0008022 | protein C-terminus binding(GO:0008022) |
| 0.0 | 0.3 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 0.0 | 0.6 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.0 | 0.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 0.0 | 0.8 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 1.2 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.0 | 1.2 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.0 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
| 0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.0 | 0.1 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.0 | 0.1 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.0 | 0.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
| 0.0 | 1.8 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.0 | 0.2 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.0 | 0.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
| 0.0 | 1.4 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.0 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.0 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
| 0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 1.0 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.0 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.0 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.0 | 0.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.0 | 0.2 | GO:0009975 | cyclase activity(GO:0009975) |
| 0.0 | 0.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.0 | 0.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.0 | 2.3 | GO:0042393 | histone binding(GO:0042393) |
| 0.0 | 0.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.0 | 0.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.1 | 1.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.8 | 7.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.7 | 2.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.6 | 2.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.5 | 1.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.5 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.5 | 18.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.4 | 2.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 10.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 19.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.3 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.3 | 0.3 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 6.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.3 | 17.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.3 | 0.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.3 | 6.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.3 | 1.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.3 | 9.0 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.3 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.3 | 20.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 5.7 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.2 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.2 | 2.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 0.9 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.2 | 7.7 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.2 | 2.0 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 2.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 4.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.2 | 3.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 4.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.2 | 0.4 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.2 | 2.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.2 | 2.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 1.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 9.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.2 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.2 | 9.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 7.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.2 | 10.2 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 9.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 11.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 4.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 5.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 4.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 0.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 6.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 3.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.1 | 4.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 0.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 2.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 8.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.1 | 5.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 4.4 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.1 | 3.3 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 2.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 3.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 2.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 0.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 8.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 1.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.1 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 0.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 5.2 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.1 | 3.5 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 1.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 0.6 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.1 | 3.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 1.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 1.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.6 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.0 | 2.7 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 1.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 3.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 1.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 1.1 | 4.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.8 | 1.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.8 | 1.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.7 | 25.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.7 | 2.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.7 | 13.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.7 | 21.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.6 | 10.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.6 | 10.9 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.6 | 13.1 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.6 | 10.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.6 | 14.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.5 | 25.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.5 | 14.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.5 | 13.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.5 | 2.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.5 | 2.0 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.5 | 10.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.5 | 6.6 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.5 | 8.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.5 | 14.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.4 | 18.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.4 | 15.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.4 | 4.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.4 | 2.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.4 | 0.4 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.4 | 6.2 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.4 | 3.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.4 | 9.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.4 | 4.7 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.4 | 8.3 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.4 | 9.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.4 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.4 | 3.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.4 | 3.9 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.3 | 1.4 | REACTOME LAGGING STRAND SYNTHESIS | Genes involved in Lagging Strand Synthesis |
| 0.3 | 6.7 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.3 | 7.6 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.3 | 1.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.3 | 7.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.3 | 5.9 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.3 | 14.8 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.3 | 1.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.3 | 10.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.3 | 9.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.3 | 12.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.3 | 7.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.3 | 5.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.3 | 4.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.3 | 5.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.3 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.3 | 5.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 0.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.2 | 2.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 5.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.2 | 19.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 21.0 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.2 | 6.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.2 | 8.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.2 | 2.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.2 | 4.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 2.0 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
| 0.2 | 5.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 3.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.2 | 5.4 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.2 | 4.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.2 | 1.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 5.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.2 | 2.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 7.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 1.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 7.3 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 4.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 4.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 4.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.2 | 3.7 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 4.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 6.9 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 3.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 1.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.2 | 1.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.2 | 5.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 0.2 | 4.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 2.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.2 | 3.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 4.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.2 | 2.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.2 | 2.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.2 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.2 | 3.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.2 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 4.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 3.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.2 | 3.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.2 | 3.9 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
| 0.1 | 2.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 2.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.1 | 3.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 6.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 13.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 2.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 3.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 6.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 21.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 2.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 3.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 2.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 20.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 4.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 3.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 0.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.1 | 7.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 1.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.1 | 0.6 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 8.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 1.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
| 0.1 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.1 | 2.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.0 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 1.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.1 | 5.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 5.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 1.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 9.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.1 | 4.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 3.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 0.9 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.1 | 0.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 3.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 1.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.1 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 4.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.1 | 6.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 1.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.1 | 0.6 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
| 0.1 | 4.3 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.1 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.1 | 2.5 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
| 0.1 | 0.8 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
| 0.1 | 5.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 0.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 0.4 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.1 | 0.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.1 | 0.5 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.1 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 16.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.0 | 2.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 2.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.0 | 0.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.0 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.0 | 0.6 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.0 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.0 | 0.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 0.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |